J&J | JNJ - Ebitda


J&J reported $8.99B in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
AbbVie USD 6.91B 3.22B Jun/2026
Abbott USD 2.43B 844M Mar/2026
Amgen USD 5.8B 1.25B Sep/2026
AstraZeneca USD 7.46B 2.3B Sep/2026
Baxter International USD 474M 165M Jun/2026
Bayer EUR 1.62B 529M Sep/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Biogen USD 450.8M 198.9M Jun/2026
Boston Scientific USD 1.63B 27M Jun/2026
Bristol-Myers Squibb USD 3.48B 1.6B Sep/2026
CONMED USD 67.88M 10.24M Sep/2026
Cooper Companies USD 67.9M 255.5M Mar/2026
Dexcom USD 435.2M 46.5M Sep/2026
Edwards Lifesciences USD 562.2M 6.6M Jun/2026
Eli Lilly USD 9.46B 3.54B Sep/2026
Gilead Sciences USD -9.31B 12.82B Jun/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Globus Medical USD 262.21M 17.63M Sep/2026
Insulet USD 233.7M 33.9M Sep/2026
Integra LifeSciences USD 79.79M 1.37M Sep/2026
Intuitive Surgical USD 1.2B 147.7M Jun/2026
J&J USD 8.99B 721M Jun/2026
Medtronic USD 2.63B 174M Jun/2026
Merck USD 1.42B 2.97B Jun/2026
Merit Medical Systems USD 103.93M 461K Sep/2026
Novartis USD 8.62B 2.14B Sep/2026
Pfizer USD 6.36B 350M Sep/2026
Regeneron Pharmaceuticals USD 1.66B 695.2M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 5.79B 2.1B Sep/2026
Stryker USD 1.83B 102M Sep/2026
Tandem Diabetes Care USD 18.04M 11.62M Sep/2026
Teva Pharmaceutical Industries USD 1.5B 1.02B Sep/2026
Vertex Pharmaceuticals USD 888.6M 436.6M Sep/2026
Zimmer Biomet Holdings USD 634.8M 195.7M Sep/2026
Zoetis USD 1.07B 21M Sep/2026